Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOSCA IT: Pioglitazone vs Sulphonylurea in Type 2 Diabetes
NCT00700856Phase 4Unknown
- Sponsor
- Società Italiana di Diabetologia
- Start
- Sep 2008
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pioglitazone in type 2 diabetes mellitus (T2DM), sponsored by Società Italiana di Diabetologia. Status: unknown.
02
Drugs
pioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00700856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00700856.